Statements (53)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:healthcare_organization
|
| gptkbp:affects |
lymphatic system
|
| gptkbp:can_metastasize_to |
initial treatment
|
| gptkbp:caused_by |
lymphadenopathy
extranodal involvement |
| gptkbp:exhibits |
weight loss
fever night sweats swollen lymph nodes |
| gptkbp:has_achievements |
secondary infections
tumor lysis syndrome |
| https://www.w3.org/2000/01/rdf-schema#label |
primary ALCL
|
| gptkbp:is_a |
type of lymphoma
|
| gptkbp:is_associated_with |
autoimmune diseases
viral infections immune system disorders ALK gene rearrangement |
| gptkbp:is_characterized_by |
large atypical lymphoid cells
C D4 positive T-cells |
| gptkbp:is_considered |
a subtype of peripheral T-cell lymphoma
a rare lymphoma |
| gptkbp:is_evaluated_by |
oncologists
hematologists |
| gptkbp:is_monitored_by |
blood tests
imaging studies |
| gptkbp:is_often_used_in |
gptkb:Person
young adults females males |
| gptkbp:is_part_of |
hematologic malignancies
lymphoma classification |
| gptkbp:is_recognized_by |
specific biomarkers
|
| gptkbp:is_related_to |
gptkb:healthcare_organization
gptkb:non-Hodgkin_lymphoma |
| gptkbp:is_studied_in |
clinical trials
genetic mutations treatment responses |
| gptkbp:occurs_in |
gptkb:skincare_product
bone marrow lymph nodes |
| gptkbp:scientific_classification |
C D30 positive lymphoma
|
| gptkbp:social_responsibility |
biopsy
flow cytometry immunohistochemistry variable outcomes |
| gptkbp:treatment |
gptkb:brentuximab_vedotin
palliative care radiation therapy chemotherapy targeted therapy stem cell transplant |
| gptkbp:bfsParent |
gptkb:secondary_ALCL
|
| gptkbp:bfsLayer |
7
|